Return On Equity in % of BELLICUM PHARMACEUTICALS, INC from Q3 2015 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BELLICUM PHARMACEUTICALS, INC quarterly/annual Return On Equity history and change rate from Q3 2015 to Q3 2023.
  • BELLICUM PHARMACEUTICALS, INC Return On Equity for the quarter ending 30 Sep 2023 was 157 %.
  • BELLICUM PHARMACEUTICALS, INC annual Return On Equity for 2022 was -244 %, a 193% decline from 2021.
  • BELLICUM PHARMACEUTICALS, INC annual Return On Equity for 2021 was 261 %, a 800% increase from 2020.
  • BELLICUM PHARMACEUTICALS, INC annual Return On Equity for 2020 was 29 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BELLICUM PHARMACEUTICALS, INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 157 +260 01 Jul 2023 30 Sep 2023
Q2 2023 516 +587 01 Apr 2023 30 Jun 2023
Q1 2023 -753 -597 -384% 01 Jan 2023 31 Mar 2023
Q4 2022 -244 -505 -193% 01 Oct 2022 31 Dec 2022
Q3 2022 -103 -39.9 -63.6% 01 Jul 2022 30 Sep 2022
Q2 2022 -71.4 -48.6 -213% 01 Apr 2022 30 Jun 2022
Q1 2022 -156 -286 -219% 01 Jan 2022 31 Mar 2022
Q4 2021 261 +232 +800% 01 Oct 2021 31 Dec 2021
Q3 2021 -62.7 -233 -137% 01 Jul 2021 30 Sep 2021
Q2 2021 -22.8 -451 -105% 01 Apr 2021 30 Jun 2021
Q1 2021 130 -15.1K -99.1% 01 Jan 2021 31 Mar 2021
Q4 2020 29 +830 01 Oct 2020 31 Dec 2020
Q3 2020 170 +464 01 Jul 2020 30 Sep 2020
Q2 2020 428 +597 01 Apr 2020 30 Jun 2020
Q1 2020 15.2K +15.3K 01 Jan 2020 31 Mar 2020
Q4 2019 -801 -685 -594% 01 Oct 2019 31 Dec 2019
Q3 2019 -294 -189 -182% 01 Jul 2019 30 Sep 2019
Q2 2019 -169 -68.5 -68% 01 Apr 2019 30 Jun 2019
Q1 2019 -123 -24.6 -25% 01 Jan 2019 31 Mar 2019
Q4 2018 -115 -34.5 -42.7% 01 Oct 2018 31 Dec 2018
Q3 2018 -104 -27.1 -35.1% 01 Jul 2018 30 Sep 2018
Q2 2018 -101 -30.1 -42.5% 01 Apr 2018 30 Jun 2018
Q1 2018 -98.4 -35 -55.1% 01 Jan 2018 31 Mar 2018
Q4 2017 -80.9 -22.9 -39.5% 01 Oct 2017 31 Dec 2017
Q3 2017 -77.2 -27.5 -55.4% 01 Jul 2017 30 Sep 2017
Q2 2017 -70.7 -28.5 -67.6% 01 Apr 2017 30 Jun 2017
Q1 2017 -63.4 -28.3 -80.3% 01 Jan 2017 31 Mar 2017
Q4 2016 -58 -29.5 -103% 01 Oct 2016 31 Dec 2016
Q3 2016 -49.7 +9.23 +15.7% 01 Jul 2016 30 Sep 2016
Q2 2016 -42.2 01 Apr 2016 30 Jun 2016
Q1 2016 -35.2 01 Jan 2016 31 Mar 2016
Q4 2015 -28.5 01 Oct 2015 31 Dec 2015
Q3 2015 -58.9 01 Jul 2015 30 Sep 2015

BELLICUM PHARMACEUTICALS, INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -244 -505 -193% 01 Jan 2022 31 Dec 2022
2021 261 +232 +800% 01 Jan 2021 31 Dec 2021
2020 29 +830 01 Jan 2020 31 Dec 2020
2019 -801 -685 -594% 01 Jan 2019 31 Dec 2019
2018 -115 -34.5 -42.7% 01 Jan 2018 31 Dec 2018
2017 -80.9 -22.9 -39.5% 01 Jan 2017 31 Dec 2017
2016 -58 -29.5 -103% 01 Jan 2016 31 Dec 2016
2015 -28.5 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.